{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:34:22Z","timestamp":1792542862182,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["42-478\/2013 SR"],"award-info":[{"award-number":["42-478\/2013 SR"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increase in the number of infections caused by Gram-negative bacteria in neutropenic cancer patients has prompted the search for novel therapeutic agents having dual anticancer and antimicrobial properties. Bacteriocins are cationic proteins of prokaryotic origin that have emerged as one of the most promising alternative antimicrobial agents with applications as food preservatives and therapeutic agents. Apart from their antimicrobial activities, bacteriocins are also being explored for their anticancer potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, a broad-spectrum, cell membrane-permeabilizing enterocin with a molecular weight of 65\u2009kDa was purified and characterized from the culture supernatant of vaginal\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      12a. Enterocin 12a inhibited multidrug-resistant strains of various Gram-negative pathogens such as\n                      <jats:italic>Salmonella enterica<\/jats:italic>\n                      ,\n                      <jats:italic>Shigella flexneri<\/jats:italic>\n                      ,\n                      <jats:italic>Vibrio cholerae<\/jats:italic>\n                      ,\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      and Gram-positive,\n                      <jats:italic>Listeria monocytogenes,<\/jats:italic>\n                      but had no activities against different strains of gut lactobacilli. The mass spectrometric analysis showed that the enterocin 12a shared partial homology with 4Fe-4S domain-containing redox protein of\n                      <jats:italic>E. faecalis<\/jats:italic>\n                      R712. Further, enterocin 12a selectively inhibited the proliferation of various human cancer cell lines in a dose-dependent manner but not that of normal human peripheral blood mononuclear cells. Enterocin 12a-treated cancer cells showed apoptosis-like morphological changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Enterocin 12a is a novel bacteriocin that has anticancer properties against human cell lines and negligible activity towards non-malignant cells. Therefore, it should be further evaluated for its anticancer potential in animal models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-021-02086-5","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T02:04:07Z","timestamp":1612404247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Anticancer and antimicrobial potential of enterocin 12a from Enterococcus faecium"],"prefix":"10.1186","volume":"21","author":[{"given":"Preeti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder Singh","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raminderjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2703-170X","authenticated-orcid":false,"given":"Sukhraj","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"2086_CR1","volume-title":"World Cancer report","author":"International Agency of Research on Cancer [IARC]","year":"2018","unstructured":"International Agency of Research on Cancer [IARC]. World Cancer report. Geneva: World-Health-Organisation; 2018."},{"issue":"Suppl 5","key":"2086_CR2","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.1093\/cid\/ciu598","volume":"59","author":"T Holland","year":"2014","unstructured":"Holland T, Fowler VG Jr, Shelburne SA III. Invasive gram-positive bacterial infection in cancer patients. Clin Infect Dis. 2014;59(Suppl 5):S331\u20134. https:\/\/doi.org\/10.1093\/cid\/ciu598.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2086_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-9378-7-33","volume":"7","author":"K Alibek","year":"2012","unstructured":"Alibek K, Bekmurzayeva A, Mussabekova A, Sultankulov B. Using antimicrobial adjuvant therapy in cancer treatment: a review. Infect Agent Cancer. 2012;7(1):33. https:\/\/doi.org\/10.1186\/1750-9378-7-33.","journal-title":"Infect Agent Cancer"},{"key":"2086_CR4","doi-asserted-by":"publisher","unstructured":"Rodrigues G, Silva GG, Buccini DF, Duque HM, Dias SC, Franco OL. Bacterial proteinaceous compounds with multiple activities toward cancers and microbial infection. Front Microbiol. 2019;10. https:\/\/doi.org\/10.3389\/fmicb.2019.01690.","DOI":"10.3389\/fmicb.2019.01690"},{"issue":"5","key":"2086_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ijantimicag.2015.07.011","volume":"46","author":"VL Cavera","year":"2015","unstructured":"Cavera VL, Arthur TD, Kashtanov D, Chikindas ML. Bacteriocins and their position in the next wave of conventional antibiotics. Int J Antimicrob Agents. 2015;46(5):494\u2013501.","journal-title":"Int J Antimicrob Agents"},{"key":"2086_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3389\/fmicb.2014.00241","volume":"5","author":"SC Yang","year":"2014","unstructured":"Yang SC, Lin CH, Sung CT, Fang JY. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 2014;5:683. https:\/\/doi.org\/10.3389\/fmicb.2014.00241.","journal-title":"Front Microbiol"},{"key":"2086_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-1605(01)00560-8","volume":"71","author":"J Cleveland","year":"2001","unstructured":"Cleveland J, Montville TJ, Nes IF, Chikindas ML. Bacteriocins: safe, natural antimicrobials for 18 h for food preservation. Int J Food Microbiol. 2001;71:1\u201320.","journal-title":"Int J Food Microbiol"},{"key":"2086_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3389\/fmicb.2017.01205","volume":"8","author":"H Mathur","year":"2017","unstructured":"Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP. Bacteriocin-antimicrobial synergy: a medical and food perspective. Front Microbiol. 2017;8:1205.","journal-title":"Front Microbiol"},{"key":"2086_CR9","doi-asserted-by":"publisher","unstructured":"Hols P, Ledesma-Garc\u00eda L, Gabant P, Mignolet J. Mobilization of microbiota commensals and their bacteriocins for therapeutics. Trends Microbiol. 2019; doi:org\/https:\/\/doi.org\/10.1016\/j.tim.","DOI":"10.1016\/j.tim"},{"key":"2086_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/0890334408317435","volume":"24","author":"L Fern\u00e1ndez","year":"2008","unstructured":"Fern\u00e1ndez L, Delgado S, Herrero H, Maldonado A, Rodr\u00edguez JM. The bacteriocin nisin, an effective agent for the treatment of Staphylococcal mastitis during lactation. J Hum Lact. 2008;24:311\u20136. https:\/\/doi.org\/10.1177\/0890334408317435.","journal-title":"J Hum Lact"},{"key":"2086_CR11","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1128\/AAC.00629-07","volume":"51","author":"J Wu","year":"2007","unstructured":"Wu J, Hu S, Cao L. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother. 2007;51:3131\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"2086_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/cam4.35","volume":"1","author":"NE Joo","year":"2012","unstructured":"Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1:295\u201305.","journal-title":"Cancer Med."},{"key":"2086_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fphar.2015.00272","volume":"6","author":"S Kaur","year":"2015","unstructured":"Kaur S, Kaur S. Bacteriocins as potential anticancer agents. Front Pharmacol. 2015;6:272.","journal-title":"Front Pharmacol"},{"key":"2086_CR14","doi-asserted-by":"publisher","unstructured":"Perez RH, Zendo T, Sonomoto K. Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Fact. 2014;13:S3. doi.org\/https:\/\/doi.org\/10.1186\/1475-2859-13-S1-S3.","DOI":"10.1186\/1475-2859-13-S1-S3"},{"issue":"Suppl 1","key":"2086_CR15","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","volume":"39","author":"J Klastersky","year":"2004","unstructured":"Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis. 2004;39(Suppl 1):S32\u20137.","journal-title":"Clin Infect Dis"},{"key":"2086_CR16","doi-asserted-by":"crossref","unstructured":"Sharma P, Kaur S, Kaur R, Kaur M, Kaur S. Proteinaceous secretory metabolites of probiotic human commensal Enterococcus hirae 20c, E. faecium 12a and L12b as antiproliferative agents against cancer cell lines. Front Microbiol. 2018;9:948.","DOI":"10.3389\/fmicb.2018.00948"},{"key":"2086_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1128\/AAC.01569-06","volume":"52","author":"JE Line","year":"2008","unstructured":"Line JE, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Svetoch OE, Seal BS, Siragusa GR, Stern NJ. Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 2008;52:1094\u2013100.","journal-title":"Antimicrob Agents Chemother"},{"key":"2086_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11274-015-1973-4","volume":"32","author":"H Liu","year":"2016","unstructured":"Liu H, Zhang L, Yi H, Han X, Gao W, Chi C, Song W, Li H, Liu C. A novel enterocin T1 with anti-Pseudomonas activity produced by Enterococcus faecium T1 from Chinese Tibet cheese. World J Microbiol Biotechnol. 2016;32:21.","journal-title":"World J Microbiol Biotechnol"},{"key":"2086_CR19","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1099\/00221287-143-7-2287","volume":"143","author":"P Casaus","year":"1997","unstructured":"Casaus P, Nilsen T, Cintas L, Nes I, Hern\u00e1ndez P, Holo H. Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin a. Microbiology. 1997;143:2287\u201394.","journal-title":"Microbiology."},{"key":"2086_CR20","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1128\/aem.63.11.4321-4330.1997","volume":"63","author":"LM Cintas","year":"1997","unstructured":"Cintas LM, Casaus P, H\u00e5varstein LS, Hern\u00e1ndez PE, Nes IF. Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum. Appl Environ Microbiol. 1997;63:4321\u201330.","journal-title":"Appl Environ Microbiol"},{"key":"2086_CR21","doi-asserted-by":"publisher","first-page":"22706","DOI":"10.3390\/ijms151222706","volume":"15","author":"MJ Grande Burgos","year":"2014","unstructured":"Grande Burgos MJ, Pulido RP, L\u00f3pez Aguayo DCM, G\u00e1lvez A, Lucas R. The cyclic antibacterial peptide enterocin AS-48: isolation, mode of action, and possible food applications. Int J Mol Sci. 2014;15:22706\u201327.","journal-title":"Int J Mol Sci"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1172\/JCI34005","volume":"118","author":"WA Petri","year":"2008","unstructured":"Petri WA, Miller M, Binder HJ, Levine MM, Dillingham R, Guerrant RL. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest. 2008;118:1277\u201390.","journal-title":"J Clin Invest"},{"key":"2086_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"2086_CR24","unstructured":"WHO. Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including Mycobacterium tuberculosis. 2017. WHO\/EMP\/IAU\/2017.11Geneva:WHO."},{"key":"2086_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1099\/00221287-142-4-817","volume":"142","author":"L De Vuyst","year":"1996","unstructured":"De Vuyst L, Callewaert R, Crabb\u00e9 K. Primary metabolite kinetics of bacteriocin biosynthesis by Lactobacillus amylovorus and evidence for stimulation of bacteriocin production under unfavourable growth conditions. Microbiology. 1996;142:817\u201327.","journal-title":"Microbiology."},{"key":"2086_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/toxins5050895","volume":"5","author":"D Van Tyne","year":"2013","unstructured":"Van Tyne D, Martin MJ, Gilmore MS. Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins. 2013;5:895\u2013911.","journal-title":"Toxins."},{"key":"2086_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1574-6976.2007.00064.x","volume":"31","author":"CM Franz","year":"2007","unstructured":"Franz CM, Van Belkum MJ, Holzapfel WH, Abriouel H, G\u00e1lvez A. Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol Rev. 2007;31:293\u2013310.","journal-title":"FEMS Microbiol Rev"},{"key":"2086_CR28","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1128\/AEM.69.5.2975-2984.2003","volume":"69","author":"T Nilsen","year":"2003","unstructured":"Nilsen T, Nes IF, Holo H. Enterolysin a, a cell wall-degrading bacteriocin from Enterococcus faecalis LMG 2333. Appl Environ Microbiol. 2003;69:2975\u201384.","journal-title":"Appl Environ Microbiol"},{"key":"2086_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1128\/JB.02203-14","volume":"197","author":"J Kurushima","year":"2015","unstructured":"Kurushima J, Nakane D, Nishizaka T, Tomita H. Bacteriocin protein Bacl1 of Enterococcus faecalis targets cell division loci and specifically recognizes L-Ala2-cross-bridged peptidoglycan. J Bacteriol. 2015;197:286\u201395.","journal-title":"J Bacteriol"},{"key":"2086_CR30","doi-asserted-by":"publisher","first-page":"e0186415","DOI":"10.1371\/journal.pone.0186415","volume":"12","author":"U Phumisantiphong","year":"2017","unstructured":"Phumisantiphong U, Siripanichgon K, Reamtong O, Diraphat P. A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci. PLoS One. 2017;12:e0186415.","journal-title":"PLoS One"},{"key":"2086_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1471-2180-12-132","volume":"12","author":"RM Shekh","year":"2012","unstructured":"Shekh RM, Roy U. Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalis. BMC Microbiol. 2012;12:132.","journal-title":"BMC Microbiol"},{"key":"2086_CR32","doi-asserted-by":"crossref","unstructured":"Vasilchenko AS, Vasilchenko AV, Valyshev AV, Rogozhin EA. A novel high-molecular-mass bacteriocin produced by Enterococcus faecium: biochemical features and mode of action. Probiotics Antimicrob Proteins. 2018:1\u20138.","DOI":"10.1007\/s12602-018-9392-0"},{"key":"2086_CR33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nature08301","volume":"460","author":"R Lill","year":"2009","unstructured":"Lill R. Function and biogenesis of iron-Sulphur proteins. Nature. 2009;460:831\u20138.","journal-title":"Nature."},{"key":"2086_CR34","doi-asserted-by":"publisher","first-page":"e33033","DOI":"10.1371\/journal.pone.0033033","volume":"7","author":"R Grinter","year":"2012","unstructured":"Grinter R, Milner J, Walker D. Ferredoxin containing bacteriocins suggest a novel mechanism of iron uptake in Pectobacterium spp. PLoS One. 2012;7:e33033.","journal-title":"PLoS One"},{"key":"2086_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/mmi.12655","volume":"93","author":"R Grinter","year":"2014","unstructured":"Grinter R, Josts I, Zeth K, Roszak AW, McCaughey LC, Cogdell RJ, Milner JJ, Kelly SM, Byron O, Walker D. Structure of the atypical bacteriocin pectocin M2 implies a novel mechanism of protein uptake. Mol Microbiol. 2014;93:234\u201346.","journal-title":"Mol Microbiol"},{"key":"2086_CR36","doi-asserted-by":"publisher","first-page":"e01961","DOI":"10.1128\/mBio.01961-16","volume":"8","author":"MG Ghequire","year":"2017","unstructured":"Ghequire MG, Kemland L, Anoz-Carbonell E, Buchanan SK, De Mot R. A natural chimeric Pseudomonas bacteriocin with novel pore-forming activity parasitizes the ferrichrome transporter. MBio. 2017;8:e01961\u20132016.","journal-title":"MBio."},{"key":"2086_CR37","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/gbe\/evt111","volume":"5","author":"M de Been","year":"2013","unstructured":"de Been M, van Schaik W, Cheng L, Corander J, Willems RJ. Recent recombination events in the core genome are associated with adaptive evolution in Enterococcus faecium. Genome Biol Evol. 2013;5:1524\u201335.","journal-title":"Genome Biol Evol"},{"key":"2086_CR38","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1128\/AEM.70.4.2098-2104.2004","volume":"70","author":"T Keren","year":"2004","unstructured":"Keren T, Yarmus M, Halevy G, Shapira R. Immunodetection of the bacteriocin lacticin RM: analysis of the influence of temperature and tween 80 on its expression and activity. Appl Environ Microbiol. 2004;70:2098\u201304.","journal-title":"Appl Environ Microbiol"},{"key":"2086_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mimet.2005.10.008","volume":"66","author":"ME Weeks","year":"2006","unstructured":"Weeks ME, von Caron GN, James DC, Smales CM, Robinson GK. Monitoring changes in nisin susceptibility of Listeria monocytogenes Scott a as an indicator of growth phase using FACS. J Microbiol Methods. 2006;66:43\u201355.","journal-title":"J Microbiol Methods"},{"key":"2086_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10123-002-0063-2","volume":"5","author":"M Dalmau","year":"2002","unstructured":"Dalmau M, Maier E, Mulet N, Vinas M, Benz R. Bacterial membrane injuries induced by lactacin F and nisin. Int Microbiol. 2002;5:73\u201380.","journal-title":"Int Microbiol"},{"key":"2086_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jff.2017.09.034","volume":"38","author":"D Ankaiah","year":"2017","unstructured":"Ankaiah D, Esakkiraj P, Perumal V, Ayyanna R, Venkatesan A. Probiotic characterization of Enterococcus faecium por1: cloning, over expression of Enterocin-a and evaluation of antibacterial, anticancer properties. J Funct Foods. 2017;38:280\u201392.","journal-title":"J Funct Foods"},{"key":"2086_CR42","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11274-010-0541-1","volume":"27","author":"KI Villarante","year":"2011","unstructured":"Villarante KI, Elegado FB, Iwatani S, Zendo T, Sonomoto K, de Guzman EE. Purification and characterization and in vitro cytotoxicity of the bacteriocin from Pediococcus acidilactici K2a2-3 against human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells. World J Microbiol Biotechnol. 2011;27:975\u201380.","journal-title":"World J Microbiol Biotechnol"},{"key":"2086_CR43","first-page":"249","volume":"2013","author":"SL Sand","year":"1828","unstructured":"Sand SL, Nissen-Meyer J, Sand O, Haug TM. Plantaricin a, a cationic peptide produced by Lactobacillus plantarum, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins. Biochim Biophys Acta. 1828;2013:249\u201359.","journal-title":"Biochim Biophys Acta"},{"key":"2086_CR44","doi-asserted-by":"publisher","first-page":"e0131008","DOI":"10.1371\/journal.pone.0131008","volume":"10","author":"P Kamarajan","year":"2015","unstructured":"Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, Worden F, Kapila S, Kapila Y. Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PLoS One. 2015;10:e0131008.","journal-title":"PLoS One"},{"key":"2086_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/cam4.35","volume":"1","author":"NE Joo","year":"2012","unstructured":"Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YI. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1:295\u201305.","journal-title":"Cancer Med"},{"key":"2086_CR46","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.1128\/IAI.70.12.7054-7062.2002","volume":"70","author":"T Yamada","year":"2002","unstructured":"Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Gupta TD, Chakrabarty AM. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect Immun. 2002;70:7054\u201362.","journal-title":"Infect Immun"},{"key":"2086_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.phrs.2005.06.002","volume":"52","author":"DS Yang","year":"2005","unstructured":"Yang DS, Miao XD, Ye ZM, Feng J, Xu RZ, Huang X, Ge FF. Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells. Pharmacol Res. 2005;52:413\u201321.","journal-title":"Pharmacol Res"},{"key":"2086_CR48","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1080\/15384101.2016.1179034","volume":"15","author":"AM Chakrabarty","year":"2016","unstructured":"Chakrabarty AM. Bacterial azurin in potential cancer therapy. Cell Cycle. 2016;15:1665\u20137.","journal-title":"Cell Cycle"},{"key":"2086_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-005-3557-3","volume":"276","author":"I Dobrzy\u0144ska","year":"2005","unstructured":"Dobrzy\u0144ska I, Szachowicz-Petelska B, Figaszewski Z, Sulkowski S. Changes in electric charge and phospholipid composition in human colorectal cancer cells. Mol Cell Biochem. 2005;276:113\u20139.","journal-title":"Mol Cell Biochem"},{"key":"2086_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","volume":"1778","author":"DW Hoskin","year":"2008","unstructured":"Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochem Biophys Acta. 2008;1778:357\u201375.","journal-title":"Biochem Biophys Acta"},{"key":"2086_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0304-3835(99)00044-0","volume":"139","author":"M Sok","year":"1999","unstructured":"Sok M, Sentjurc M, Schara M. Membrane fluidity characteristics of human lung cancer. Cancer Lett. 1999;139:215\u201320.","journal-title":"Cancer Lett"},{"key":"2086_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2303.1995.tb00469.x","volume":"6","author":"J Chaudhary","year":"1995","unstructured":"Chaudhary J, Munshi M. Scanning electron microscopic analysis of breast aspirates. Cytopathology. 1995;6:162\u20137.","journal-title":"Cytopathology."},{"key":"2086_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1155\/1999\/176515","volume":"19","author":"M Leite","year":"1999","unstructured":"Leite M, Quinta-Costa M, Leite PS, Guimar\u00e3es JE. Critical evaluation of techniques to detect and measure cell death-study in a model of UV radiation of the leukaemic cell line HL60. Anal Cell Pathol. 1999;19:139\u201351.","journal-title":"Anal Cell Pathol"},{"key":"2086_CR54","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.onc.1207376","volume":"23","author":"V Punj","year":"2004","unstructured":"Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene. 2004;23:2367\u201378.","journal-title":"Oncogene."},{"key":"2086_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature15524","volume":"526","author":"S Kommineni","year":"2015","unstructured":"Kommineni S, Bretl DJ, Lam V, Chakraborty R, Hayward M, Simpson P, Cao Y, Bousounis P, Kristich CJ, Salzman NH. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature. 2015;526:719\u201322.","journal-title":"Nature."},{"key":"2086_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1128\/aem.45.1.205-211.1983","volume":"45","author":"A Geis","year":"1983","unstructured":"Geis A, Singh J, Teuber M. Potential of lactic streptococci to produce bacteriocin. Appl Environ Microbiol. 1983;45:205\u201311.","journal-title":"Appl Environ Microbiol"},{"key":"2086_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"key":"2086_CR58","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680\u20135.","journal-title":"Nature."},{"key":"2086_CR59","first-page":"241","volume":"19","author":"DC Dezwaan","year":"2007","unstructured":"Dezwaan DC, Mequio MJ, Littell JS, Allen JP, Rossbach S, Pybus V. Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: potential significance in bacterial vaginosis. Microb Ecol Health Dis. 2007;19:241\u201350.","journal-title":"Microb Ecol Health Dis"},{"key":"2086_CR60","doi-asserted-by":"publisher","first-page":"13412","DOI":"10.1038\/srep13412","volume":"5","author":"L Chopra","year":"2015","unstructured":"Chopra L, Singh G, Jena KK, Sahoo DK. Sonorensin: a new bacteriocin with potential of an anti-biofilm agent and a food biopreservative. Sci Rep. 2015;5:13412.","journal-title":"Sci Rep"},{"key":"2086_CR61","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1099\/mic.0.062190-0","volume":"158","author":"AD Paiva","year":"2012","unstructured":"Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiology. 2012;158:2851\u20138.","journal-title":"Microbiology."},{"key":"2086_CR62","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1128\/IAI.68.6.3581-3586.2000","volume":"68","author":"C Hessle","year":"2000","unstructured":"Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun. 2000;68:3581\u20136.","journal-title":"Infect Immun"},{"key":"2086_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363.","journal-title":"J Immunol Methods"},{"key":"2086_CR64","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495\u201316.","journal-title":"Toxicol Pathol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-021-02086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-021-02086-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-021-02086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T18:05:22Z","timestamp":1674929122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-021-02086-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1186\/s12866-021-02086-5","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For RBCs isolation, the blood of healthy individuals above 18\u2009yrs. of age was drawn after taking their written informed consent. The protocol was approved by the Institutional Human Ethics Committee, Guru Nanak Dev University, and performed in accordance with the guidelines of the Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}